Literature DB >> 366017

The derivation of a minimum immune titre of rubella haemagglutination-inhibition (HI) antibody. A Public Health Laboratory Service collaborative survey.

C M Bradstreet, B Kirkwood, J R Pattison, J O Tobin.   

Abstract

Ten laboratories collaborated in a study of minimum immune titre (MIT) of rubella haemagglutination-inhibiting (HI) antibody with one laboratory acting as a reference laboratory to provide a uniform basis for comparison of the HI results. The international unitage equivalent to the MIT used by the ten laboratories was found to vary from 24 to 98 units. Testing of the sera by immunofluorescence and by HI after flotation centrifugation indicated that residual non-specific inhibitors may interfere with HI antibody testing to an extent equivalent to 12-15 units. An acceptable MIT would therefore be equivalent to 24-48 units of rubella HI antibody. The single radial haemolysis (SRH) results on the sera indicate that this is a sensitive and specific test for rubella antibody.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 366017      PMCID: PMC2130054          DOI: 10.1017/s0022172400025262

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  4 in total

1.  Hemolysis-in-gel test for the demonstration of antibodies to rubella virus.

Authors:  O Strannegård; L Grillner; I M Lindberg
Journal:  J Clin Microbiol       Date:  1975-06       Impact factor: 5.948

2.  False positive rubella virus haemagglutination inhibition reactions: occurrence and disclosure.

Authors:  G Haukenes; H Blom
Journal:  Med Microbiol Immunol       Date:  1975       Impact factor: 3.402

3.  Identification of non-specific serum inhibitors of rubella virus haemagglutination.

Authors:  H Blom; G Haukenes
Journal:  Med Microbiol Immunol       Date:  1974-06-19       Impact factor: 3.402

4.  IgG, IgA and IgM responses in acute rubella determined by the immunofluorescent technique.

Authors:  J E Cradock-Watson; M S Bourne; E M Vandervelde
Journal:  J Hyg (Lond)       Date:  1972-09
  4 in total
  15 in total

Review 1.  Laboratory diagnosis of rubella: past, present and future.

Authors:  J E Cradock-Watson
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

Review 2.  HIV vaccine development: strategies for preclinical and clinical investigation.

Authors:  Stuart Z Shapiro
Journal:  AIDS Res Hum Retroviruses       Date:  2013-03-08       Impact factor: 2.205

3.  A comparison of three tests for rubella antibody screening.

Authors:  P Morgan-Capner; H J Pullen; J R Pattison; D E Bidwell; A Bartlett; A Voller
Journal:  J Clin Pathol       Date:  1979-06       Impact factor: 3.411

4.  Rubella vaccination: remaining problems.

Authors:  J E Banatvala
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-01

5.  Failure of rubella immunisation after blood transfusion.

Authors:  J E Banatvala; J M Best; M L King; C E James
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-28

6.  Rubella antibody screening.

Authors:  J R Pattison
Journal:  J Hyg (Lond)       Date:  1982-04

7.  Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories.

Authors:  J B Kurtz; P P Mortimer; P R Mortimer; P Morgan-Capner; M S Shafi; G B White
Journal:  J Hyg (Lond)       Date:  1980-04

8.  Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females.

Authors:  S Gudmundsdóttir; A Antonsdóttir; S Gudnadóttir; S Elefsen; B Einarsdóttir; O Olafsson; M Gudnadóttir
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

Review 9.  Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies.

Authors:  Wayne Dimech; Liliane Grangeot-Keros; Christelle Vauloup-Fellous
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

10.  Fetal infection resulting from maternal rubella after the first trimester of pregnancy.

Authors:  J E Cradock-Watson; M K Ridehalgh; M J Anderson; J R Pattison; H O Kangro
Journal:  J Hyg (Lond)       Date:  1980-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.